ISSN 1004-4140
CN 11-3017/P
陈小勇, 徐敬慈, 李芹芹, 等. CT征象对胰腺神经内分泌肿瘤侵袭性行为的预测价值[J]. CT理论与应用研究, 2022, 31(3): 399-407. DOI: 10.15953/j.ctta.2021.082.
引用本文: 陈小勇, 徐敬慈, 李芹芹, 等. CT征象对胰腺神经内分泌肿瘤侵袭性行为的预测价值[J]. CT理论与应用研究, 2022, 31(3): 399-407. DOI: 10.15953/j.ctta.2021.082.
CHEN X Y, XU J C, LI Q Q, et al. The predictive value of CT findings in invasive behavior of pancreatic neuroendocrine tumors[J]. CT Theory and Applications, 2022, 31(3): 399-407. DOI: 10.15953/j.ctta.2021.082. (in Chinese).
Citation: CHEN X Y, XU J C, LI Q Q, et al. The predictive value of CT findings in invasive behavior of pancreatic neuroendocrine tumors[J]. CT Theory and Applications, 2022, 31(3): 399-407. DOI: 10.15953/j.ctta.2021.082. (in Chinese).

CT征象对胰腺神经内分泌肿瘤侵袭性行为的预测价值

The Predictive Value of CT Findings in Invasive Behavior of Pancreatic Neuroendocrine Tumors

  • 摘要: 目的:探讨胰腺神经内分泌肿瘤(pNET)的CT征象对其侵袭性行为的预测价值。方法:回顾性分析经手术病理确诊、临床及CT资料完整、术前均行胰腺CT平扫及增强检查的120例pNET,分析病灶的部位、形态、包膜、有无囊变和钙化、有无胰管扩张、肿瘤的强化方式,测量肿瘤最大径、最短径以及实性部分平扫、动脉期及门脉期密度,并计算动脉期强化差值、门脉期强化差值。根据手术病理结果将肿瘤分为侵袭组和无侵袭组,比较两组间CT征象的差异。使用绘制受试者操作特征(ROC)曲线评价肿瘤最大径、最短径、动脉期差值和门脉期差值对pNET的侵袭性行为的预测价值。结果:侵袭组和无侵袭组pNET在发病部位、胰管扩张、囊变、钙化及强化方式无差异,在形态、完整包膜上有差异。两组在最大径、最短径、动脉期强化差值、门脉期强化差值定量特征有差异,其ROC曲线下面积为0.693、0.69、0.73和0.64,具有判别效能。对6个差异有统计学意义的影像特征通过多变量Logistic回归分析,结果显示动脉期强化差值为判断pNET侵袭性行为的独立预测因素,动脉期强化差值最佳临界点为90.1 HU(灵敏度0.714,特异性0.656,阳性预测值64.5%,阴性预测值72.4%,准确率68.3%)。结论:胰腺神经内分泌肿瘤体积大、形态不规则、包膜不完整或无包膜,肿瘤实性成分动脉期、门脉期强化差值低等征象提示肿瘤具有侵袭性行为,其中动脉期强化差值为pNET侵袭性行为的独立预测因素。

     

    Abstract: Objective: To explore the value of CT findings in predicting the invasive behaviors of pancreatic neuroendocrine tumor (pNET). Methods: The clinical data and CT data of 120 patients with pNET confirmed by surgical resection and pathology were retrospectively analyzed. Preoperative CT plain scan and enhanced examination of pancreas were performed. Image analysis included tumor location, shape, capsule, cystic change, calcification, pancreatic duct dilation and enhancement pattern. The maximum and minimum diameter of the tumor were measured. The CT value of the solid part of the tumor was measured in plain scan, arterial phase and portal vein phase. Enhancement difference in arterial phase and portal vein phase were calculated. The tumors were divided into invasive group and non-invasive group according to the pathological results. The difference of CT findings between the two groups was compared. Receivers operating characteristic (ROC) curves were drawn to evaluate the predictive value of tumor maximum diameter, minimum diameter, enhancement difference in arterial phase and portal vein phase on the invasive behavior of pNET. Results: There were no statistical differences in tumor location, pancreatic duct dilation, cystic change, calcification and enhancement pattern between the invasive and non-invasive groups. There were statistically significant differences between the two groups in the quantitative characteristics of the maximum diameter, the minimum diameter, enhancement difference in arterial phase and portal vein phase and the areas under ROC curve were 0.693, 0.69, 0.73 and 0.64, indicating discrimination efficiency. Multivariate Logistic regression analysis of 6 meaningful image features showed that arterial enhancement difference was an independent predictor of pNET invasive behavior, and the optimal critical point of arterial enhancement difference was 90.1HU (sensitivity 0.714, specificity 0.656, positive predictive value 64.5%, negative predictive value 72.4%, accuracy 68.3%). Conclusion <b<:</b< Large volume, irregular shape, incomplete or no capsule of pancreatic neuroendocrine tumor, and low enhancement difference of solid tumor components in arterial and portal phases suggested invasive behavior of tumor, and enhancement difference in arterial phase was an independent predictor of invasive behavior of pNET.

     

/

返回文章
返回